The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 07, 2019

Filed:

Jun. 15, 2017
Applicant:

The Chemo-sero-therapeutic Research Institute, Kumamoto-shi, JP;

Inventors:

Ryuichi Sakamoto, Kumamoto, JP;

Masashi Sakaguchi, Kikuchi, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/102 (2006.01); C12N 7/00 (2006.01); A61K 39/112 (2006.01); A61K 39/02 (2006.01); A61K 39/215 (2006.01); A61K 39/235 (2006.01); A61K 39/295 (2006.01); A61K 39/04 (2006.01); A61K 39/00 (2006.01); A61K 39/17 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0275 (2013.01); A61K 39/025 (2013.01); A61K 39/0208 (2013.01); A61K 39/0241 (2013.01); A61K 39/04 (2013.01); A61K 39/102 (2013.01); A61K 39/215 (2013.01); A61K 39/235 (2013.01); A61K 39/295 (2013.01); C12N 7/00 (2013.01); A61K 39/17 (2013.01); A61K 2039/552 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/70 (2013.01); C12N 2710/10234 (2013.01); C12N 2710/10271 (2013.01); C12N 2770/20034 (2013.01); C12N 2770/20071 (2013.01);
Abstract

A vaccine composition for birds comprising as an active ingredient a structure containing O-antigen derived from Gram-negative bacteria, provided that said structure does not contain a whole cell, and a process for preparing the same are provided. By using a structure containing O-antigen (e.g. lipopolysaccharide) derived from Gram-negative bacteria as an active ingredient in accordance with the present invention, alleviation of inoculation reaction and reduction in an amount of injection are attained as compared to the conventional whole-cells vaccine to thereby allow for the increase in the number of other antigens to be mixed therewith.


Find Patent Forward Citations

Loading…